RIL
EBS icon

Rothschild Investment LLC’s Emergent Biosolutions EBS Stock Holding History

Rothschild Investment LLC’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.04K Buy
363
+119
+49% +$996 ﹤0.01% 2561
2026
Q1 		$2.02K Buy
244
+189
+344% +$1.96K ﹤0.01% 2557
2025
Q4 		$680 Buy
+55
New +$589 ﹤0.01% 2819

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Rothschild Investment LLC's EBS Position: Q2 2026 in Review

Rothschild Investment LLC increased its Emergent Biosolutions (EBS) stake by 49% in Q2 2026, buying an estimated $996 and bringing the position to 363 shares worth $3.04K. The position accounts for ﹤0.01% of the portfolio, ranked #2561.

Rothschild Investment LLC first reported a position in EBS in Q4 2025 and has held it in 3 quarters since. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Rothschild Investment LLC held 363 shares of Emergent Biosolutions worth $3.04K as of Q2 2026.
  • Rothschild Investment LLC bought 119 Emergent Biosolutions shares in Q2 2026, an estimated $996.
  • Emergent Biosolutions made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2561 holding.
  • Rothschild Investment LLC first reported a position in Emergent Biosolutions in Q4 2025 and has held it in 3 quarters since.
  • 195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.